Updated:
Duopharma Biotech Berhad
Duopharma Biotech Berhad is a biotech-focused asset manager headquartered in Kuala Lumpur, Malaysia, with additional offices in Boca Raton, Boston, San...
Duopharma Biotech Berhad
Duopharma Biotech Berhad is a biotech-focused asset manager headquartered in Kuala Lumpur, Malaysia, with additional offices in Boca Raton, Boston, San Francisco, Cambridge, and West Palm Beach. The firm appears to operate at the intersection of pharmaceutical and biotech investing, targeting opportunities across early-stage R&D through later-stage commercialization. The firm's investment strategy spans therapeutic categories including oncology, neurology, and rare diseases. Deploying via direct equity and structured financings, Duopharma Biotech Berhad participates in private placements, IPOs, and pre-commercialization rounds. Known portfolio involvement includes specialty pharmaceutical companies focused on infectious diseases and metabolic disorders. Geographically, the firm invests primarily in North American and Asian biotech markets, reflecting its dual presence in Malaysia and US biotech hubs. Total AUM and team size are not publicly disclosed. Adjacent relationships or philanthropic vehicles related to the firm are unconfirmed. A structural differentiator is Duopharma Biotech Berhad's multi-office model spanning biotech clusters in both Asia and the US, which may provide sourcing advantages in emerging-market drug development. The firm's governance structure and succession plans remain opaque, as limited public reporting is available.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
Malaysia
City
Kuala Lumpur
Corporate office
Kuala Lumpur, Malaysia
Additional offices
Boca Raton · Boston · San Francisco · Cambridge · West Palm Beach
Sector focus
Frequently asked questions
What investment stages does Duopharma Biotech Berhad typically target?
The firm appears active across early- and late-stage biotech, including private placements, IPOs, and pre-commercialization financings. Investment focus spans therapeutics from preclinical through marketed products.
Where does Duopharma Biotech Berhad deploy capital geographically?
Duopharma Biotech Berhad invests primarily in North American and Asian biotech markets, with offices in Kuala Lumpur, Boston, San Francisco, Cambridge, Boca Raton, and West Palm Beach indicating a cross-border approach.
What therapeutic areas does Duopharma Biotech Berhad focus on?
Areas of interest include oncology, neurology, rare diseases, and infectious diseases. The firm also participates in specialty pharmaceuticals and metabolic disorder treatments.
Is Duopharma Biotech Berhad structured as a single family office or an asset manager?
Public structure is unclear; the firm is described as an asset manager with offices in biotech hubs. Wealth origin and ownership detail are not publicly reported.
Does Duopharma Biotech Berhad participate in fund commitments or only direct deals?
The firm appears to engage in direct equity investments and structured financings, but no evidence of fund-of-funds or GP commitment activity has been publicly documented.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: